T. Sugimoto

发表

Predictors of survival among Japanese patients receiving first‐line chemoimmunotherapy for advanced non‐small cell lung cancer

Nozomi Tani, T. Takeda, Yusuke Tachibana, 2020, Thoracic cancer.

Osimertinib-Associated Toxic Epidermal Necrolysis in a Lung Cancer Patient Harboring an EGFR Mutation—A Case Report and a Review of the Literature

Nozomi Tani, T. Takeda, Yusuke Tachibana, 2020, Medicina.

Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer

Nozomi Tani, T. Takeda, Yusuke Tachibana, 2020, Thoracic cancer.

Long-term remission after autologous peripheral blood stem cell transplantation for relapsed intravascular lymphoma

I. Sugiura, H. Narimatsu, S. Kurahashi, 2006, Bone Marrow Transplantation.

Central Nervous System Relapse after Autologous Peripheral Blood Stem Cell Transplantation in Primary Plasma Cell Leukemia

K. Furukawa, H. Narimatsu, S. Kurahashi, 2006 .

Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation.

T. Naoe, T. Kinoshita, A. Tomita, 2009, Biochemical and biophysical research communications.

Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy

T. Naoe, T. Kinoshita, A. Tomita, 2007, International journal of hematology.

Difficulty of peripheral blood stem cell collection after multiple consolidation therapy in acute myeloid leukemia.

H. Narimatsu, S. Kurahashi, F. Yamamoto, 2008, Journal of clinical and experimental hematopathology : JCEH.

Prediction of clinical outcome in patients with idiopathic thrombocytopenic purpura by evaluating bone marrow clot CD20+ B lymphocytes and morphological changes of megakaryocytes.

H. Narimatsu, S. Kurahashi, Masafumi Ito, 2008, Journal of Clinical and Experimental Hematopathology.

Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia

K. Miyamura, Takahiko Sato, Y. Akatsuka, 2017, Medicine.

A resected case with secondary pancreatic carcinoma derived from small cell carcinoma of the uterine cervix

T. Oshikiri, H. Hasegawa, Tadayuki Ohara, 2014 .

Chimeric antisense RNA derived from chromosomal translocation modulates target gene expression

T. Naoe, A. Tomita, H. Kiyoi, 2012, Haematologica.

A case of adult multisystem Langerhans histiocytosis successfully treated by smoking cessation and radiotherapy for bone lesion

T. Harada, T. Sugimoto, Hiroki Hayata, 2022, Clinical case reports.

Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance.

Shigeo Nakamura, Kazuyuki Shimada, Masafumi Ito, 2009, Blood.

Down-regulation of CD 20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies : its prevalence and clinical significance

Shigeo Nakamura, Kazuyuki Shimada, Masafumi Ito, 2009 .

Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.

Takashi Watanabe, T. Sugimoto, 2016, Journal of clinical and experimental hematopathology : JCEH.

Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study

S. Kurahashi, D. Koyama, S. Nishiwaki, 2017, Japanese journal of clinical oncology.

Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study

Nozomi Tani, T. Takeda, Yusuke Tachibana, 2021, Multidisciplinary respiratory medicine.

Relationship Between Post-Translational Modification of CD20 Protein and the Responsiveness to Rituximab Treatment

T. Naoe, T. Kinoshita, A. Tomita, 2008 .